Treatment of localized soft-tissue sarcoma: Lessons learned

ONCOLOGY

Volumn 21, Issue 6, 2007, Pages 731-735

  Pisters, Peter W T ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE;

CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; RADIATION DOSE; RISK REDUCTION; SOFT TISSUE SARCOMA; TREATMENT OUTCOME; WOUND COMPLICATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SARCOMA;

EID: 34249880454     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Pisters PW, Harrison LB, Leung DH, et al: Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14:859-868, 1996.
2. Yang JC, Chang AE, Baker AR, et al: A randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197-203, 1998.
3. O'Sullivan B, Davis AM, Turcotte R, et al: Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomized trial. Lancet 359:2235-2241, 2002.
4. Frustaci S, De Paoli A, Bidoli E, et al: Ifosfamide in the adjuvant therapy of soft tissue sarcomas. Oncology 65(suppl 2):80-84, 2003.
5. Petrioli R, Coratti A, Correale P, et al: Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma. Am J Clin Oncol 25:468-473, 2002.
6. Brodowicz T, Schwameis E, Widder J, et al: Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: A prospective randomized feasibility trial. Sarcoma 4:151-160, 2000.
7. Pisters PWT, Patel SR, Varma DGK, et al: Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: Long-term results from a single institution. J Clin Oncol 15:3481-3487, 1997.